Muhammad O Awiwi

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Muhammad O Awiwi is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. His research focuses on medical imaging, particularly in the context of cancer staging, treatment response evaluation, and complications associated with various oncological procedures. Dr. Awiwi has contributed to recent articles covering topics such as rectal cancer MRI, thoracic aneurysm repair complications, and biomarkers in hepatocellular carcinoma.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

kathryn fowler

Associate Professor

University of California, San Diego

UNITED STATES

View details

Claude B. Sirlin

UNITED STATES

View details

Min Hanna

Assistant Professor

University of Tennessee Health Science Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Muhammad O Awiwi

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Rectal Cancer MRI: An Update

Complications of thoracic endovascular aneurysm repair (TEVAR): A pictorial review

Anatomic Basis of Rectal Cancer Staging: Clarifying Controversies and Misconceptions

Imaging Findings in Cirrhotic Liver: Pearls and Pitfalls for Diagnosis of Focal Benign and Malignant Lesions

Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls

MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.

Tyrosine Kinase Inhibitor–related Intestinal Lymphangiectasia

Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: a retrospective series of biopsy-proven cases

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification

Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification

Should We Use Magnetic Resonance Imaging for Thyroid Nodules with Indeterminate Cytology?

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Collaborators (3)

kathryn fowler

Claude B. Sirlin

Min Hanna

Make your next move.